Phase I Trial of Intra-Tumoral Gemcitabine Therapy for Locally Advanced Pancreatic Carcinoma
Phase of Trial: Phase I
Latest Information Update: 24 Mar 2017
Price : $35 *
At a glance
- Drugs Gemcitabine (Primary) ; Fluorouracil
- Indications Pancreatic cancer
- Focus Adverse reactions
- 21 Mar 2017 Status changed from discontinued to completed.
- 30 Oct 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
- 11 Aug 2013 New trial record